tiprankstipranks
RegenXBio (RGNX)
NASDAQ:RGNX
US Market

RegenXBio (RGNX) Stock Investors

Compare
912 Followers
Based on 793,704 investor portfolios analyzed by TipRanks Open your own Smart Portfolio >

Average Holdings Size

0.1% of all portfolios hold RGNX
On average, investors allocate 3.38% of their portfolios to RGNX
The average holding size of this company in investors' portfolios.

Investor Sentiment

Very Negative
Sector
Average
Stock Sentiment
Sold
Bought
Based on the activity of 793,704 investors in the recent quarter
The overall sentiment of all investors covering this stock. Click on ‘Top Investors’ to focus on the best performers.

Portfolios Holding RGNX

0.8%
Last 7
Days
6.0%
Last 30
Days
Percentages indicate the change in the number of portfolios holding RGNX, out of 793,704 portfolios.
The average increase or decrease in average holding size of this stock in investor portfolios in the last 7 days or last 30 days.

RGNX Investor Activity

Action
Any
Any
Investor Performance
Any
Any
Investor Profile
Investor Action
Transaction Date
Portfolio Allocation
Execution Price
Follow
Increased
0.22%
$9.35
Increased
<0.01%
$6.11
Based on the activity of investors who made their portfolios public
The table shows changes in RGNX in the past 3 months by investors with public portfolios.
Investor activity updates every 24 hours.

RGNX Investors Also Bought

Investor Type
Any
Any
All Investors
Name
Average Holding Size
Last 7D Change
Last 30D Change
Market Cap
Sector
3M Behavior
Follow
Viking Therapeutics
3.84%
-0.74%
-7.54%
2.96B
Healthcare
Block
3.64%
+0.58%
-1.21%
35.30B
Technology
CVS Health
4.33%
-1.68%
-6.95%
84.73B
Healthcare
Abbott Laboratories
3.41%
-0.38%
-3.87%
227.80B
Healthcare
Zscaler
3.51%
-0.08%
-4.58%
33.38B
Technology
Trade Desk
3.38%
+2.87%
+5.03%
28.41B
Technology
Bristol-Myers Squibb
3.53%
-1.05%
-5.40%
119.85B
Healthcare
Delta Air Lines
4.83%
+0.16%
-1.33%
29.81B
Industrials
Target
3.71%
-0.41%
-1.53%
48.02B
Consumer Defensive
Riot Platforms
4.58%
-0.51%
-5.85%
2.72B
Financial
Based on the activity of 793,704 active portfolios
Open your Smart Portfolio

RGNX Investor Analysis

RGNX investors under 35

Under 35

0.0%
Last 30 days
Holdings Change
11.5%
of RGNX holders
are under 35
Average Segment Performance
Average P/E Ratio18.15
Beta11.20
Dividend Yield3.92%
RGNX investors between 35–55

Between 35–55

7.3%
Last 30 days
Holdings Change
40.6%
of RGNX holders
are between 35–55
Average Segment Performance
Average P/E Ratio15.89
Beta22.53
Dividend Yield3.38%
RGNX investors over 55

Over 55

5.0%
Last 30 days
Holdings Change
47.9%
of RGNX holders
are over 55
Average Segment Performance
Average P/E Ratio13.53
Beta11.97
Dividend Yield3.63%
Overview of age group and performance of RGNX stock investors
See who invests in RGNX according to age group and performance.

FAQ

How many retail Investors hold RGNX?
0.1% of TipRanks' retail investors hold RGNX in their portfolios.
    What is RGNX Investor Sentiment?
    RGNX’s Investor Sentiment is Very Negative.
      What percentage of retail investors changed their holding of RGNX in the last 7 days?
      ▼ 0.8% of TipRanks' retail investors changed their holding of RGNX in the last 7 days.
        What percentage of retail investors changed their holding of RGNX in the last 30 days?
        ▼ 6.0% of TipRanks' retail investors changed their holding of RGNX in the last 30 days.
          What is the average age of retail investors who hold RGNX?
          The average age of RGNX Holders is over 55.
            What other stocks have RGNX investors also bought?
            RGNX Investors also bought VKTX, XYZ, CVS, ABT, ZS, TTD, BMY, DAL, TGT, RIOT.
              Stocks with the Most Positive Individual Investor Sentiment in the Healthcare sector
              ALGNAlign Tech
              ALKSAlkermes
              AZNAstraZeneca
              CNCCentene
              CHRSCoherus Biosciences
              What am I Missing?
              Make informed decisions based on Top Analysts' activity
              Know what industry insiders are buying
              Get actionable alerts from top Wall Street Analysts
              Find out before anyone else which stock is going to shoot up
              Get powerful stock screeners & detailed portfolio analysis